IL165262A0 - Kinase inhibitors - Google Patents
Kinase inhibitorsInfo
- Publication number
- IL165262A0 IL165262A0 IL16526203A IL16526203A IL165262A0 IL 165262 A0 IL165262 A0 IL 165262A0 IL 16526203 A IL16526203 A IL 16526203A IL 16526203 A IL16526203 A IL 16526203A IL 165262 A0 IL165262 A0 IL 165262A0
- Authority
- IL
- Israel
- Prior art keywords
- kinase inhibitors
- compound
- formula
- diastereomers
- solvates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- AIDS & HIV (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPS2514A AUPS251402A0 (en) | 2002-05-23 | 2002-05-23 | Kinase inhibitors |
US39899802P | 2002-07-26 | 2002-07-26 | |
PCT/AU2003/000628 WO2003099811A1 (fr) | 2002-05-23 | 2003-05-23 | Inhibiteurs de la kinase |
Publications (1)
Publication Number | Publication Date |
---|---|
IL165262A0 true IL165262A0 (en) | 2005-12-18 |
Family
ID=29585025
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16526203A IL165262A0 (en) | 2002-05-23 | 2003-05-23 | Kinase inhibitors |
IL165262A IL165262A (en) | 2002-05-23 | 2004-11-16 | Kinase inhibitors and pharmaceutical compositions containing them |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL165262A IL165262A (en) | 2002-05-23 | 2004-11-16 | Kinase inhibitors and pharmaceutical compositions containing them |
Country Status (11)
Country | Link |
---|---|
US (4) | US7259179B2 (fr) |
EP (1) | EP1511742B1 (fr) |
CN (1) | CN1671696B (fr) |
AT (1) | ATE457025T1 (fr) |
AU (1) | AU2003229370B2 (fr) |
CA (1) | CA2486187C (fr) |
DE (1) | DE60331187D1 (fr) |
GB (1) | GB2398781B (fr) |
IL (2) | IL165262A0 (fr) |
NZ (1) | NZ537156A (fr) |
WO (1) | WO2003099811A1 (fr) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4769720B2 (ja) * | 2003-08-21 | 2011-09-07 | オーエスアイ・ファーマシューテイカルズ・エル・エル・シー | N−置換ベンズイミダゾリルc−Kit阻害剤 |
US7390907B2 (en) | 2003-09-30 | 2008-06-24 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
AU2004294355B2 (en) * | 2003-12-03 | 2011-12-22 | Ym Biosciences Australia Pty Ltd | Azole-based kinase inhibitors |
JP4808628B2 (ja) | 2003-12-03 | 2011-11-02 | ワイエム・バイオサイエンシズ・オーストラリア・ピーティーワイ・リミテッド | アゾール系キナーゼ阻害剤 |
AU2005203919B2 (en) * | 2004-01-12 | 2011-07-21 | Ym Biosciences Australia Pty Ltd | Selective kinase inhibitors |
GB2432834A (en) * | 2004-01-12 | 2007-06-06 | Cytopia Res Pty Ltd | Selective Kinase Inhibitors |
MY148676A (en) * | 2004-06-04 | 2013-05-31 | Bioniche Life Sciences Inc | Use of imatinib to treat liver disorders and viral infections |
CN101193867A (zh) * | 2004-12-01 | 2008-06-04 | Osi医药有限公司 | N取代的苯并咪唑基c-Kit抑制剂和苯并咪唑组合库 |
EP1874772A1 (fr) * | 2005-04-05 | 2008-01-09 | Pharmacopeia, Inc. | Derives de purine et d'imidazopyridine en vue d'une immunosuppression |
NZ566021A (en) * | 2005-07-26 | 2011-03-31 | Vertex Pharma | Benzimidazoles useful as inhibitors of protein kinases |
US7977365B2 (en) | 2006-03-02 | 2011-07-12 | Siga Technologies, Inc. | Antiviral drugs for treatment of arenavirus infection |
US8871746B2 (en) | 2006-03-02 | 2014-10-28 | Kineta Four, LLC | Antiviral drugs for treatment of arenavirus infection |
ES2395101T3 (es) | 2006-03-02 | 2013-02-08 | Siga Technologies, Inc. | Medicamentos antivirales para tratamiento de infecciones por arenavirus |
WO2007109362A2 (fr) * | 2006-03-20 | 2007-09-27 | Synta Pharmaceuticals Corp. | Composés à base de benzoimidazolyl-parazine pour utilisations contre l'inflammation et des troubles immunitaires |
WO2007136790A2 (fr) * | 2006-05-18 | 2007-11-29 | Mannkind Corporation | Inhibiteurs de kinases intracellulaires |
WO2008058341A1 (fr) | 2006-11-15 | 2008-05-22 | Cytopia Research Pty Ltd | Inhibiteurs de l'activité kinase |
TWI415609B (zh) * | 2006-12-22 | 2013-11-21 | Astex Therapeutics Ltd | 新化合物 |
AU2007337886C1 (en) | 2006-12-22 | 2014-10-16 | Astex Therapeutics Limited | Bicyclic heterocyclic compounds as FGFR inhibitors |
PL2121687T3 (pl) * | 2006-12-22 | 2016-03-31 | Astex Therapeutics Ltd | Pochodne amin tricyklicznych jako inhibitory białkowej kinazy tyrozynowej |
US8131527B1 (en) | 2006-12-22 | 2012-03-06 | Astex Therapeutics Ltd. | FGFR pharmacophore compounds |
WO2009037247A1 (fr) * | 2007-09-17 | 2009-03-26 | Neurosearch A/S | Dérivés de pyrazine et leur utilisation en tant que modulateurs des canaux potassiques |
GB0720041D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New Compounds |
GB0720038D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New compounds |
US8008013B2 (en) * | 2007-11-16 | 2011-08-30 | Oklahoma Medical Research Foundation | Predicting and diagnosing patients with autoimmune disease |
WO2009119776A1 (fr) * | 2008-03-27 | 2009-10-01 | 武田薬品工業株式会社 | Dérivé hétérocyclique condensé et son utilisation |
EP2286224A4 (fr) * | 2008-05-05 | 2012-04-25 | Univ Winthrop Hospital | Procédé pour améliorer le profil de risque cardiovasculaire d'inhibiteurs de cox |
GB0810902D0 (en) | 2008-06-13 | 2008-07-23 | Astex Therapeutics Ltd | New compounds |
WO2010012745A2 (fr) * | 2008-07-29 | 2010-02-04 | Boehringer Ingelheim International Gmbh | Benzimidazoles |
GB0906470D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
GB0906472D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
CA2797694A1 (fr) | 2010-04-29 | 2011-11-03 | The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services | Activateurs de la pyruvate kinase humaine |
RU2591195C2 (ru) | 2010-12-13 | 2016-07-10 | Эррэй Биофарма Инк. | Замещенные n-(1h-индазол-4-ил) имидазол [1,2-а]пиридин-3- карбоксамидные соединения в качестве ингибиторов рецепторной тирозинкиназы iii типа |
US9199918B2 (en) | 2011-02-15 | 2015-12-01 | Georgetown University | Small molecule inhibitors of AGBL2 |
WO2013100208A1 (fr) | 2011-12-28 | 2013-07-04 | 京都府公立大学法人 | Normalisation d'une culture de cellules endothéliales de la cornée |
JP6412503B2 (ja) | 2012-11-21 | 2018-10-24 | ピーティーシー セラピューティクス, インコーポレイテッド | 置換逆ピリミジンBmi−1阻害剤 |
US9815815B2 (en) | 2013-01-10 | 2017-11-14 | Pulmokine, Inc. | Non-selective kinase inhibitors |
JP2016520532A (ja) * | 2013-03-15 | 2016-07-14 | ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ | ベンゾイミダゾール誘導体およびその使用 |
CN111743901B (zh) | 2013-10-11 | 2023-09-12 | 普尔莫凯恩股份有限公司 | 喷雾干燥制剂 |
WO2015072580A1 (fr) | 2013-11-14 | 2015-05-21 | 学校法人同志社 | Médicament pour traiter un endothélium cornéen favorisant une prolifération cellulaire ou inhibant un dommage cellulaire |
EP3071553A4 (fr) * | 2013-11-21 | 2017-08-02 | PTC Therapeutics, Inc. | Inhibiteurs de bmi-1 à base de pyridine et de pyrazine substituées |
WO2018013430A2 (fr) | 2016-07-12 | 2018-01-18 | Arisan Therapeutics Inc. | Composés hétérocycliques pour le traitement d'une infection à arenavirus |
AU2017348354B2 (en) | 2016-10-27 | 2023-06-15 | Pulmokine, Inc. | Combination therapy for treating pulmonary hypertension |
WO2023220046A1 (fr) * | 2022-05-10 | 2023-11-16 | Biogen Ma Inc. | Inhibiteurs de tyk2 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL215901B1 (pl) * | 1999-04-15 | 2014-02-28 | Bristol Myers Squibb Co | Cykliczny inhibitor bialkowych kinaz tyrozynowych, jego zastosowanie oraz kompozycja farmaceutyczna zawierajaca taki zwiazek |
US7125875B2 (en) * | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
US20040102455A1 (en) | 2001-01-30 | 2004-05-27 | Burns Christopher John | Method of inhibiting kinases |
GB0215775D0 (en) | 2002-07-06 | 2002-08-14 | Astex Technology Ltd | Pharmaceutical compounds |
-
2003
- 2003-05-23 CA CA2486187A patent/CA2486187C/fr not_active Expired - Fee Related
- 2003-05-23 IL IL16526203A patent/IL165262A0/xx active IP Right Grant
- 2003-05-23 US US10/472,156 patent/US7259179B2/en active Active
- 2003-05-23 EP EP03722065A patent/EP1511742B1/fr not_active Expired - Lifetime
- 2003-05-23 AT AT03722065T patent/ATE457025T1/de not_active IP Right Cessation
- 2003-05-23 CN CN038174529A patent/CN1671696B/zh not_active Expired - Fee Related
- 2003-05-23 WO PCT/AU2003/000628 patent/WO2003099811A1/fr active Application Filing
- 2003-05-23 AU AU2003229370A patent/AU2003229370B2/en not_active Ceased
- 2003-05-23 DE DE60331187T patent/DE60331187D1/de not_active Expired - Lifetime
- 2003-05-23 GB GB0318343A patent/GB2398781B/en not_active Expired - Lifetime
- 2003-05-23 NZ NZ537156A patent/NZ537156A/en not_active IP Right Cessation
-
2004
- 2004-11-16 IL IL165262A patent/IL165262A/en unknown
-
2006
- 2006-04-04 US US11/397,982 patent/US7511047B2/en not_active Expired - Lifetime
- 2006-04-04 US US11/397,973 patent/US7598272B2/en not_active Expired - Lifetime
-
2007
- 2007-02-27 US US11/711,957 patent/US20070161635A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003229370B2 (en) | 2009-02-26 |
GB2398781B (en) | 2005-02-02 |
GB0318343D0 (en) | 2003-09-10 |
US7598272B2 (en) | 2009-10-06 |
CA2486187C (fr) | 2013-02-19 |
ATE457025T1 (de) | 2010-02-15 |
EP1511742A1 (fr) | 2005-03-09 |
US7511047B2 (en) | 2009-03-31 |
CA2486187A1 (fr) | 2003-12-04 |
US20060241112A1 (en) | 2006-10-26 |
US20060270687A1 (en) | 2006-11-30 |
DE60331187D1 (de) | 2010-03-25 |
US7259179B2 (en) | 2007-08-21 |
GB2398781A (en) | 2004-09-01 |
NZ537156A (en) | 2007-06-29 |
IL165262A (en) | 2011-10-31 |
US20050004140A1 (en) | 2005-01-06 |
CN1671696B (zh) | 2010-12-08 |
CN1671696A (zh) | 2005-09-21 |
EP1511742A4 (fr) | 2006-07-05 |
EP1511742B1 (fr) | 2010-02-03 |
AU2003229370A1 (en) | 2003-12-12 |
US20070161635A1 (en) | 2007-07-12 |
WO2003099811A1 (fr) | 2003-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2392154B (en) | Protein Kinase Inhibitors | |
GB2398781B (en) | Kinase inhibitors | |
SG128491A1 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
AP1699A (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
JO2311B1 (en) | Alkyl inhibitors Ariel phosphodiesterase-4 | |
GB0111523D0 (en) | Chemical compounds | |
BRPI0407841A (pt) | inibidores heterocìclicos de quinase | |
TW200508199A (en) | Novel compound | |
SG139747A1 (en) | Inhibitors of the mutant form of kit | |
AP2002002466A0 (en) | 3-heterocycliylpropanohydroxamic acid PCP INHIBITORS. | |
AU2001263278A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
EA200600898A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
MY136938A (en) | New process for the synthesis of perindopril and its pharmaceutically acceptable salts | |
MY139159A (en) | Method for synthesis of perindopril and its pharmaceutically acceptable salts | |
MY135359A (en) | New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof | |
MY136288A (en) | New process for the synthesis of perindopril and its pharmaceutically acceptable salts | |
EA200600456A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
MY136638A (en) | New process for the synthesis of perindopril and its pharmaceutically acceptable salts | |
EA200601086A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
MY136989A (en) | New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof | |
UA80905C2 (en) | Method for synthesis of perindopril and its pharmaceutically acceptable salts | |
MY149837A (en) | New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof | |
WO2002067866A3 (fr) | Nouveaux inhibiteurs de metalloprotease matricielle | |
EA200600249A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
UA100002C2 (en) | Normal;heading 1;heading 2;heading 3;PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted |